| (Values in U.S. Thousands) | Apr, 2025 | Jan, 2025 | Oct, 2024 | Jul, 2024 | Apr, 2024 |
| Sales | 4,940 | 4,330 | 4,490 | 3,840 | 4,760 |
| Sales Growth | +14.09% | -3.56% | +16.93% | -19.33% | +3.48% |
| Net Income | -1,770 | -15,140 | -1,870 | -2,920 | -13,350 |
| Net Income Growth | +88.31% | -709.63% | +35.96% | +78.13% | -512.39% |
Immunoprecise Antibodies Ltd (IPA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
ImmunoPrecise Antibodies Ltd. is a technology platform company with end-to-end solutions empowering companies to discover and develop therapies against any disease. ImmunoPrecise Antibodies Ltd. is based in VICTORIA.